EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY 4.0

Guidelines for the management of Helicobacter pylori infection in Japan: 2024 revised edition

Hajime Isomoto iD, Tadashi Shimoyama iD, Masanori Ito, Takako Osaki iD, Osamu Toyoshima iD, Juntaro Matsuzaki, Hiroyoshi Ota, Daisuke Chinda iD, Mitsushige Sugimoto iD, Soichiro Sue iD, Koji Otani iD, Toshihiro Nishishizawa iD und 17 weitere

Journal of Gastroenterology · 2026-07 · 61 (7) · 841-862

DOI: 10.1007/s00535-026-02379-4 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Journal of Gastroenterology, online erschienen am 28.03.2026. Verfasst von Hajime Isomoto und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Nephrology, Tottori University School of Medicine, Yonago, Japan. Hauptthemen laut MEDLINE: Helicobacter Infections, Helicobacter pylori. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The Japanese Society for Helicobacter Research (JSHR) published the fifth edition of the guidelines for the management of Helicobacter pylori ( H. pylori ) infection in 2024 in Japanese language.

Methods

This edition of JSHR guidelines was first developed in accordance with the Minds Clinical Practice Guideline and Grading of Recommendations Assessment, Development, and Evaluation system. This was published after inviting public comments and external evaluations. Consensus on clinical questions (CQs) was achieved using the modified Delphi method.

Results

There was no change in the basic policy that all H. pylori infectious diseases are indications for eradication. Nucleic acid amplification was added to the diagnostic methods. Effects of proton-pump inhibitors (PPIs) on diagnostic tests were updated. The superiority of potassium-competitive acid blockers to PPIs in 1-week triple therapy with amoxicillin and clarithromycin has been shown. A flowchart for eradication therapy was provided for use in real-world settings. For gastric cancer prevention, eradication in earlier age is recommended. The most appropriate test and treatment strategies for adolescents are also described. Some CQs concerning gastric cancer prevention were identified, although evidence level was insufficient to make recommendations based on clinical importance.

Conclusion

The revised guidelines facilitate the appropriate management of H. pylori infection and gastric cancer prevention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter InfectionsHelicobacter pyloriHumansJapanAnti-Bacterial AgentsProton Pump InhibitorsStomach NeoplasmsDrug Therapy, Combination

Stichwörter der Autor:innen

Helicobacter pyloriClinical questionsDiagnosisEradicationGastric cancer prevention

Substanzen

Anti-Bacterial AgentsProton Pump Inhibitors

Autor:innen und Institutionen

  • Department of Gastroenterology and Nephrology, Tottori University School of Medicine, Yonago, Japan.
  • Aomori General Health Examination Center, Aomori, Japan.
  • Department of General Internal Medicine, Hiroshima University Hospital, Hiroshima, Japan.
  • Department of Infectious Diseases, Kyorin University School of Medicine, Mitaka, Japan.
  • Gastroenterology, Toyoshima Endoscopy Clinic, Tokyo, Japan.
  • Keio University Faculty of Pharmacy, Tokyo, Japan.

ORCID-Profile: Hajime Isomoto, Tadashi Shimoyama, Takako Osaki, Osamu Toyoshima, Daisuke Chinda, Mitsushige Sugimoto, Soichiro Sue, Koji Otani, Toshihiro Nishishizawa, Osamu Handa, Takahisa Furuta, Hideki Mori, Masumi Okuda, Yuji Nadatani, Ryota Niikura, Kazuo Yashima, Tamaki Ikuse, Toshihiko Kakiuchi, Momoko Tsuda, Kazunari Murakami, Hidekazu Suzuki

Zitieren

APA

Isomoto, H., Shimoyama, T., Ito, M., Osaki, T., Toyoshima, O., Matsuzaki, J., Ota, H., Chinda, D., Sugimoto, M., Sue, S., Otani, K., Nishishizawa, T., Handa, O., Furuta, T., Mori, H., Okuda, M., Ikebuchi, Y., Inoue, K., Sakai, K., …, & Suzuki, H. (2026). Guidelines for the management of Helicobacter pylori infection in Japan: 2024 revised edition. Journal of Gastroenterology, 61(7), 841-862. https://doi.org/10.1007/s00535-026-02379-4

Vancouver

Isomoto H, Shimoyama T, Ito M, Osaki T, Toyoshima O, Matsuzaki J, et al. Guidelines for the management of Helicobacter pylori infection in Japan: 2024 revised edition. Journal of Gastroenterology. 2026;61(7):841-862. doi:10.1007/s00535-026-02379-4

BibTeX
@article{Isomoto2026,
  author = {Isomoto, Hajime and Shimoyama, Tadashi and Ito, Masanori and Osaki, Takako and Toyoshima, Osamu and Matsuzaki, Juntaro and Ota, Hiroyoshi and Chinda, Daisuke and Sugimoto, Mitsushige and Sue, Soichiro and Otani, Koji and Nishishizawa, Toshihiro and Handa, Osamu and Furuta, Takahisa and Mori, Hideki and Okuda, Masumi and Ikebuchi, Yuichiro and Inoue, Kazuhiko and Sakai, Kyoko and Nadatani, Yuji and Niikura, Ryota and Yashima, Kazuo and Ikuse, Tamaki and Kakiuchi, Toshihiko and Tsuda, Momoko and Mabe, Katsuhiro and Mizuno, Yasuhiro and Murakami, Kazunari and Suzuki, Hidekazu},
  title = {Guidelines for the management of Helicobacter pylori infection in Japan: 2024 revised edition},
  journal = {Journal of Gastroenterology},
  year = {2026},
  volume = {61},
  number = {7},
  pages = {841--862},
  doi = {10.1007/s00535-026-02379-4}
}
Kostenlos starten →